Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.34% | -0.53% | 0.03% | 12.79% | 22.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.34% | -0.53% | 0.03% | 12.79% | 22.14% |
| Cost of Revenue | 4.39% | -6.75% | -6.59% | -5.08% | -2.70% |
| Gross Profit | 14.26% | 3.78% | 4.76% | 28.68% | 46.81% |
| SG&A Expenses | -12.78% | -13.86% | -0.87% | 9.35% | 18.44% |
| Depreciation & Amortization | -26.94% | -36.92% | -30.59% | -18.40% | -7.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.18% | -10.58% | -4.43% | 1.44% | 6.45% |
| Operating Income | 151.92% | 100.38% | 41.36% | 49.58% | 51.94% |
| Income Before Tax | 156.75% | 105.65% | 43.35% | 52.22% | 52.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 155.70% | 104.70% | 43.35% | 52.22% | 52.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 155.70% | 104.70% | 49.48% | 73.53% | 74.58% |
| EBIT | 151.92% | 100.38% | 41.36% | 49.58% | 51.94% |
| EBITDA | 170.77% | 110.37% | 43.13% | 51.37% | 53.51% |
| EPS Basic | 154.82% | 104.55% | 50.17% | 73.97% | 74.87% |
| Normalized Basic EPS | 155.74% | 105.38% | 46.74% | 56.75% | 57.68% |
| EPS Diluted | 150.55% | 101.94% | 55.91% | 74.20% | 75.03% |
| Normalized Diluted EPS | 155.74% | 105.38% | 46.74% | 56.75% | 57.68% |
| Average Basic Shares Outstanding | 1.08% | 1.34% | 1.53% | 1.72% | 1.20% |
| Average Diluted Shares Outstanding | 1.23% | 1.46% | 1.62% | 1.72% | 1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |